Skip to main content
Erschienen in: Journal of Cancer Education 4/2015

01.12.2015

Feasibility Study of Engaging Barbershops for Prostate Cancer Education in Rural African-American Communities

verfasst von: John S. Luque, Siddhartha Roy, Yelena N. Tarasenko, Levi Ross, Jarrett Johnson, Clement K. Gwede

Erschienen in: Journal of Cancer Education | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

The barbershop is a promising setting where African-American men might receive information and education about prostate cancer. In this study, we assessed the feasibility of engaging rural barbershops as venues for barbers to deliver a prostate cancer education intervention to increase informed decision-making for prostate cancer screening among customers. Twelve barbershops were recruited from two separate micropolitan areas in Georgia as intervention and control sites. Structured interviews were conducted with 11 barbers in both sites about customer characteristics as well as their willingness to participate in the study. The interviews were audio recorded and transcribed for analysis. In the intervention site, six barbers completed a survey and a pre-/posttest prostate cancer knowledge instrument following training classes. Barbers reported a wide average range of customers served per week (50 to 300). African-American men made up an average of 87 % of customers. Barbers thought prostate cancer was an important discussion topic, felt they would be comfortable discussing it, and supported the participation of their barbershop in the study. For intervention group barbers, there was a statistically significant difference between the average pretest knowledge score of 72 % (mean 12.2, SD = 3.2) and the posttest knowledge score of 89 % (mean 15.2, SD = 1.1) (P = 0.03) on the 17-item prostate cancer knowledge instrument. Based on the multiple interactions with the barbers, there was high receptivity to the topic and consensus about the importance of addressing prostate cancer with their customers. Rural barbershops represent feasible venues for delivering a prostate cancer education intervention.
Literatur
1.
Zurück zum Zitat Siegel R, Ma J, Zou Z, Jemal A (2013) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29CrossRef Siegel R, Ma J, Zou Z, Jemal A (2013) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29CrossRef
2.
Zurück zum Zitat American Cancer Society (2013) Cancer facts & figures for African Americans 2012–2013. American Cancer Society, Atlanta American Cancer Society (2013) Cancer facts & figures for African Americans 2012–2013. American Cancer Society, Atlanta
4.
Zurück zum Zitat US Cancer Statistics Working Group (2010) United States cancer statistics: 1999–2007 incidence and mortality Web-based report. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta US Cancer Statistics Working Group (2010) United States cancer statistics: 1999–2007 incidence and mortality Web-based report. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
5.
Zurück zum Zitat Reynolds D (2008) Prostate cancer screening in African American men: barriers and methods for improvement. Am J Mens Health 2(2):172–177CrossRefPubMed Reynolds D (2008) Prostate cancer screening in African American men: barriers and methods for improvement. Am J Mens Health 2(2):172–177CrossRefPubMed
6.
Zurück zum Zitat Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H et al (2008) Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 17(10):2825–2834CrossRefPubMed Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H et al (2008) Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 17(10):2825–2834CrossRefPubMed
7.
Zurück zum Zitat Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ et al (2010) American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 60(2):70–98CrossRefPubMed Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ et al (2010) American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 60(2):70–98CrossRefPubMed
8.
Zurück zum Zitat Linder SK, Kallen MA, Mullen PD, Galliher JM, Swank PR, Chan EC et al (2014) Physician behaviors to promote informed decisions for prostate cancer screening: a national research network study. J Cancer Educ 29(2):345–349CrossRefPubMed Linder SK, Kallen MA, Mullen PD, Galliher JM, Swank PR, Chan EC et al (2014) Physician behaviors to promote informed decisions for prostate cancer screening: a national research network study. J Cancer Educ 29(2):345–349CrossRefPubMed
9.
Zurück zum Zitat Volk RJ, Linder SK, Kallen MA, Galliher JM, Spano MS, Mullen PD et al (2013) Primary care physicians’ use of an informed decision-making process for prostate cancer screening. Ann Fam Med 11(1):67–74PubMedCentralCrossRefPubMed Volk RJ, Linder SK, Kallen MA, Galliher JM, Spano MS, Mullen PD et al (2013) Primary care physicians’ use of an informed decision-making process for prostate cancer screening. Ann Fam Med 11(1):67–74PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Institute of Medicine (2003) Unequal treatment: confronting racial and ethnic disparities in healthcare. The National Academies, Washington Institute of Medicine (2003) Unequal treatment: confronting racial and ethnic disparities in healthcare. The National Academies, Washington
11.
Zurück zum Zitat Taksler GB, Keating NL, Cutler DM (2012) Explaining racial differences in prostate cancer mortality. Cancer 118(17):4280–4289CrossRefPubMed Taksler GB, Keating NL, Cutler DM (2012) Explaining racial differences in prostate cancer mortality. Cancer 118(17):4280–4289CrossRefPubMed
12.
Zurück zum Zitat Andriole GL, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310–1319PubMedCentralCrossRefPubMed Andriole GL, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310–1319PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Carroll PR, Vickers AJ (2014) Point/counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Cancer Netw 12(5 Suppl):768–771 Carroll PR, Vickers AJ (2014) Point/counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Cancer Netw 12(5 Suppl):768–771
14.
Zurück zum Zitat Luque JS, Ross L, Gwede CK (2014) Qualitative systematic review of barber-administered health education, promotion, screening and outreach programs in African-American communities. J Community Health 39(1):181–190PubMedCentralCrossRefPubMed Luque JS, Ross L, Gwede CK (2014) Qualitative systematic review of barber-administered health education, promotion, screening and outreach programs in African-American communities. J Community Health 39(1):181–190PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Luque JS, Rivers BM, Kambon M, Brookins R, Green BL, Meade CD (2010) Barbers against prostate cancer: a feasibility study for training barbers to deliver prostate cancer education in an urban African-American community. J Cancer Educ 25(1):96–100PubMedCentralCrossRefPubMed Luque JS, Rivers BM, Kambon M, Brookins R, Green BL, Meade CD (2010) Barbers against prostate cancer: a feasibility study for training barbers to deliver prostate cancer education in an urban African-American community. J Cancer Educ 25(1):96–100PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Hart A Jr, Underwood SM, Smith WR, Bowen DJ, Rivers BM, Jones RA et al (2008) Recruiting African-American barbershops for prostate cancer education. J Natl Med Assoc 100(9):1012–1020PubMed Hart A Jr, Underwood SM, Smith WR, Bowen DJ, Rivers BM, Jones RA et al (2008) Recruiting African-American barbershops for prostate cancer education. J Natl Med Assoc 100(9):1012–1020PubMed
17.
Zurück zum Zitat Fraser M, Brown H, Homel P, Macchia RJ, LaRosa J, Clare R et al (2009) Barbers as lay health advocates—developing a prostate cancer curriculum. J Natl Med Assoc 101(7):690–697PubMed Fraser M, Brown H, Homel P, Macchia RJ, LaRosa J, Clare R et al (2009) Barbers as lay health advocates—developing a prostate cancer curriculum. J Natl Med Assoc 101(7):690–697PubMed
18.
Zurück zum Zitat Luque JS, Rivers BM, Gwede CK, Kambon M, Green BL, Meade CD (2011) Barbershop communications on prostate cancer screening using barber health advisers. Am J Mens Health 5(2):129–139PubMedCentralCrossRefPubMed Luque JS, Rivers BM, Gwede CK, Kambon M, Green BL, Meade CD (2011) Barbershop communications on prostate cancer screening using barber health advisers. Am J Mens Health 5(2):129–139PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Allen JD, Mohllajee AP, Shelton RC, Drake BF, Mars DR (2009) A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men. Am J Mens Health 3(4):340–351PubMedCentralCrossRefPubMed Allen JD, Mohllajee AP, Shelton RC, Drake BF, Mars DR (2009) A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men. Am J Mens Health 3(4):340–351PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Holmes-Rovner M, Kroll J, Schmitt N, Rovner DR, Breer ML, Rothert ML et al (1996) Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Dec Making 16(1):58–64CrossRef Holmes-Rovner M, Kroll J, Schmitt N, Rovner DR, Breer ML, Rothert ML et al (1996) Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Dec Making 16(1):58–64CrossRef
21.
Zurück zum Zitat O'Connor AM (1995) Validation of a decisional conflict scale. Med Dec Making 15(1):25–30CrossRef O'Connor AM (1995) Validation of a decisional conflict scale. Med Dec Making 15(1):25–30CrossRef
22.
Zurück zum Zitat Brawner BM, Baker JL, Stewart J, Davis ZM, Cederbaum J, Jemmott LS (2013) “The black man’s country club”: assessing the feasibility of an HIV risk-reduction program for young heterosexual African American men in barbershops. Fam Community Health 36(2):109–118PubMedCentralCrossRefPubMed Brawner BM, Baker JL, Stewart J, Davis ZM, Cederbaum J, Jemmott LS (2013) “The black man’s country club”: assessing the feasibility of an HIV risk-reduction program for young heterosexual African American men in barbershops. Fam Community Health 36(2):109–118PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Hart A Jr, Bowen DJ (2004) The feasibility of partnering with African-American barbershops to provide prostate cancer education. Ethn Dis 14(2):269–273PubMed Hart A Jr, Bowen DJ (2004) The feasibility of partnering with African-American barbershops to provide prostate cancer education. Ethn Dis 14(2):269–273PubMed
24.
Zurück zum Zitat Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M et al (2011) Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 171(4):342–350PubMedCentralCrossRefPubMed Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M et al (2011) Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 171(4):342–350PubMedCentralCrossRefPubMed
Metadaten
Titel
Feasibility Study of Engaging Barbershops for Prostate Cancer Education in Rural African-American Communities
verfasst von
John S. Luque
Siddhartha Roy
Yelena N. Tarasenko
Levi Ross
Jarrett Johnson
Clement K. Gwede
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2015
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0739-2

Weitere Artikel der Ausgabe 4/2015

Journal of Cancer Education 4/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.